APA (7th ed.) Citation

Wang, B., Lin, B., Zheng, D., Cao, L., & Peruchetti, D. (2026). Qingxin Lianzi Yin Improves Chronic Kidney Disease by Targeting Ferroptosis via the TLR4/HIF‐1α Pathway. Mediators of Inflammation, 2026, 1. https://doi.org/10.1155/mi/7440641

Chicago Style (17th ed.) Citation

Wang, Binqi, Bo Lin, Danna Zheng, Luxi Cao, and Diogo Peruchetti. "Qingxin Lianzi Yin Improves Chronic Kidney Disease by Targeting Ferroptosis via the TLR4/HIF‐1α Pathway." Mediators of Inflammation 2026 (2026): 1. https://doi.org/10.1155/mi/7440641.

MLA (9th ed.) Citation

Wang, Binqi, et al. "Qingxin Lianzi Yin Improves Chronic Kidney Disease by Targeting Ferroptosis via the TLR4/HIF‐1α Pathway." Mediators of Inflammation, vol. 2026, 2026, p. 1, https://doi.org/10.1155/mi/7440641.